Solid Biosciences Inc (SLDB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 8,094 | 13,620 | 0 |
| Gross Profit | N/A | N/A | 8,094 | 13,620 | N/A |
| Operating Expenses | 129,728 | 104,252 | 114,546 | 85,874 | 88,406 |
| Operating Income | -129,728 | -104,252 | -106,452 | -72,254 | -88,406 |
| Interest Expense | 340 | 440 | 0 | 0 | 0 |
| Other Income | 5,371 | 8,677 | 20,471 | 66 | 116 |
| Pre-tax Income | -124,697 | -96,015 | -85,981 | -72,188 | -88,290 |
| Net Income Continuous | -124,697 | -96,015 | -85,981 | -72,188 | -88,290 |
| Net Income | $-124,697 | $-96,015 | $-85,981 | $-72,188 | $-88,290 |
| EPS Basic Total Ops | -3.06 | -4.83 | -10.10 | -10.14 | -25.50 |
| EPS Basic Continuous Ops | -3.06 | -4.83 | -10.10 | -10.14 | -25.50 |
| EPS Diluted Total Ops | -3.06 | -4.83 | -10.10 | -10.14 | -25.50 |
| EPS Diluted Continuous Ops | -3.06 | -4.83 | -10.10 | -10.14 | -25.50 |
| EPS Diluted Before Non-Recurring Items | -2.95 | -4.83 | -10.10 | -10.20 | -24.89 |
| EBITDA(a) | $-130,865 | $-104,079 | $-103,811 | $-68,173 | $-84,504 |